封面
市場調查報告書
商品編碼
1574957

抗菌藥物抗藥性監測市場,按技術、按應用、按最終用戶、按國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Antimicrobial Resistance Surveillance Market, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年抗菌藥物抗藥性監測市場規模為59.0409億美元,2024年至2032年複合年成長率為5.90%。

抗菌藥物抗藥性監測市場-市場動態

醫療保健相關感染的增加需要加強監測和控制措施。

抗菌素抗藥性 (AMR) 發生率的上升是 AMR 監測市場的重要驅動力,因為它對全球健康構成威脅。抗藥性感染的日益流行導致醫療保健當局優先考慮監測和研究措施以應對這場危機。

據美國疾病管制與預防中心 (CDC) 稱,美國每年發生近 300 萬例抗生素抗藥性感染,凸顯了加強監測系統的迫切需求。隨著政府和教育機構對抗菌素抗藥性監測的投資,對創新技術和技術的需求持續成長,使其成為投資和研究的關鍵領域。

抗菌素抗藥性監測市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 5.90% 左右的複合年成長率成長

基於技術細分,PCR(聚合酶鍊式反應)預計將在 2023 年顯示最大的市場佔有率

按應用細分,2023年公共衛生監測為主導類型

根據最終用戶細分,醫院是 2023 年的領先類型

按地區分類,北美是 2023 年的主要收入來源

抗菌素抗藥性監測市場-細分分析:

全球抗菌素抗藥性監測市場根據技術、應用、最終用戶和地區進行細分。

市場依技術分為六類:微生物培養、免疫測定、PCR(聚合酶鍊式反應)、NGS(次世代定序)、質譜、快速和即時照護等。 PCR(聚合酶鍊式反應)是抗菌素抗藥性監測市場中最重要的部分。 PCR 很受歡迎,因為它可以快速且準確地檢測抗藥性細菌。

這種方法的工作原理是擴增特定的 DNA 序列,更容易識別病原體及其抗性基因。其速度和精確度對於醫療機構的及時反應至關重要,有助於有效控制和管理感染。隨著抗生素抗藥性日益受到關注,PCR 在監測中的作用不斷擴大。

市場根據應用分為三類:公共衛生監測、實驗室監測、臨床診斷和其他。公共衛生監測是抗菌素抗藥性 (AMR) 監測市場中最重要的部分。該方法涉及收集和分析抗菌素抗藥性資料,以幫助衛生當局監測趨勢和疫情。

公共衛生監測對於做出明智的政策決策、指導治療計畫和有效分配資源至關重要。透過識別不同人群中的特定抗藥性菌株,這種方法可以採取有針對性的措施來減輕抗藥性的傳播。它在改善患者治療結果和加強公共衛生策略方面的作用使其成為抗菌素抗藥性領域的關鍵參與者,影響未來抗菌管理和感染控制方面的努力。

抗菌素抗藥性監測市場 - 地理洞察

由於人們越來越擔心標準治療無效的感染,北美的抗菌素抗藥性 (AMR) 監測市場正在不斷成長。該地區擁有完善的醫療保健系統和監管機構,支持抗菌素抗藥性的監測和研究。醫療保健計劃資金的增加和先進技術的發展正在推動市場成長。

公眾意識活動強調了追蹤抗生素抗藥性的重要性,進一步增加了對監測技術的需求。總體而言,北美正在努力改進對抗抗生素抗藥性和保持人們健康的方法。

抗菌素抗藥性監測市場-競爭格局:

由於抗藥性感染正在成為全球範圍內的一個更大問題,因此抗菌素抗藥性 (AMR) 監測市場正在快速成長。 Thermo Fisher Scientific、bioMerieux、BD(Becton、Dickinson 和 Company)和 Cepheid 等公司透過創建先進的工具和系統來檢測和追蹤這些抗藥性細菌,從而處於領先地位。他們專注於測試方法、自動化系統和全球網路來監測阻力趨勢。

政府、醫療保健組織和這些公司之間的合作正在幫助市場成長。資料分析和機器學習的改進使得預測抗菌素抗藥性模式變得更加容易,使這個市場對公共衛生非常重要。

最新進展:

2024 年 2 月,Visby Medical 推出了快速淋病測試,其中包括抗菌藥物抗藥性分析,以應對日益嚴重的抗藥性感染挑戰。這項創新旨在提高淋病的治療效果和公共衛生管理

2023 年 11 月,Ginkgo Bioworks 和 XWELL 宣布擴大其基於 CDC 旅行者的基因組監測計畫。該措施旨在透過檢測旅行者體內 30 多種已知病原體來加強公共衛生工作,從而提高監測和預防潛在疫情爆發的能力。

目錄

第 1 章:抗菌藥物抗藥性監測市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按技術分類的抗菌素抗藥性監測市場片段
    • 按應用分類的抗菌素抗藥性監測市場片段
    • 最終用戶的抗菌素抗藥性監測市場片段
    • 按國家/地區分類的抗菌素抗藥性監測市場片段
    • 按地區分類的抗菌素抗藥性監測市場片段
  • 競爭洞察

第 3 章:抗菌素抗藥性監測主要市場趨勢

  • 抗菌素抗藥性監測市場促進因素
    • 市場促進因素的影響分析
  • 抗菌素抗藥性監測市場限制
    • 市場限制影響分析
  • 抗菌素抗藥性監測市場機會
  • 抗菌素抗藥性監測市場未來趨勢

第 4 章:抗菌素抗藥性監測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:抗菌藥物抗藥性監測市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:抗菌素抗藥性監測市場格局

  • 2023 年抗菌藥物抗藥性監測市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:抗菌藥物抗藥性監測市場 - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 微生物學培養
    • 免疫分析
    • 聚合酶鍊式反應
    • NGS
    • 質譜分析
    • 快速和照護端
    • 其他

第 8 章:抗菌藥物抗藥性監測市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 公共衛生監測
    • 實驗室監測
    • 臨床診斷
    • 其他應用

第 9 章:抗菌藥物抗藥性監測市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 10 章:抗菌藥物抗藥性監測市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美主要製造商抗菌素抗藥性監測
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按技術)
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商抗菌素抗藥性監測
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測(按技術)
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區抗菌素抗藥性監測主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按技術)
    • 亞太地區市場規模與預測(按應用)
    • 亞太地區市場規模和預測(按最終用戶)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商的抗菌素抗藥性監測
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按技術)
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲主要製造商抗菌素抗藥性監測
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按技術)
    • 中東和非洲市場規模及預測(按應用)
    • 中東和非洲市場規模和預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章:主要供應商分析 - 抗菌藥物抗藥性監測產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • bioMerieux
    • BD (Becton, Dickinson and Company)
    • Cepheid
    • Roche Diagnostics
    • Abbott Laboratories
    • Meridian Bioscience
    • OpGen
    • T2 Biosystems
    • Luminex Corporation
    • Accelerate Diagnostics
    • Beckman Coulter
    • QIAGEN
    • Mast Group Ltd.
    • Antimicrobial Resistance Technologys (AMRS) Global

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3998

REPORT HIGHLIGHT

Antimicrobial Resistance Surveillance Market size was valued at USD 5,904.09 million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Antimicrobial resistance surveillance checks how well antibiotics and other antimicrobial drugs work against bacteria, viruses, and fungi. It helps to identify patterns of resistance, which guides healthcare providers in choosing the right treatments. This information also supports public health policies and strategies to fight the problem. By collecting data from hospitals, labs, and communities, health organizations can better understand the extent of resistance and work to lessen its impact on public health. This ongoing effort is crucial for making sure effective treatments are available for infections.

Antimicrobial Resistance Surveillance Market- Market Dynamics

Rising healthcare-associated infections necessitate enhanced surveillance and control measures.

The rising incidence of antimicrobial resistance (AMR) is a significant driver for the AMR surveillance market, as it poses a threat to global health. The increasing prevalence of resistant infections has led healthcare authorities to prioritize monitoring and research initiatives to combat this crisis.

According to the Centers for Disease Control and Prevention (CDC), nearly 3 million antibiotic-resistant infections occur in the U.S. each year, highlighting the urgent need for enhanced surveillance systems. As governments and educational institutions invest in AMR surveillance, the demand for innovative technologies and Technology continues to grow, making it a critical area for investment and research.

Antimicrobial Resistance Surveillance Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Technology segmentation, PCR (Polymerase Chain Reaction) was predicted to show maximum market share in the year 2023

Based on Application segmentation, Public Health Surveillance was the leading type in 2023

Based on End User segmentation, Hospitals was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Antimicrobial Resistance Surveillance Market- Segmentation Analysis:

The Global Antimicrobial Resistance Surveillance Market is segmented based on Technology, Application, End-User, and Region.

The market is divided into six categories based on Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (next-generation sequencing), Mass Spectrometry, Rapid & Point of Care, and Others. PCR (Polymerase Chain Reaction) is the most significant segment in the Antimicrobial Resistance Surveillance Market. PCR is popular because it allows for quick and accurate detection of resistant bacteria.

This method works by amplifying specific DNA sequences, making it easier to identify pathogens and their resistance genes. Its speed and precision make it crucial for timely responses in healthcare settings, helping to control and manage infections effectively. As antibiotic resistance becomes a growing concern, PCR's role in surveillance continues to expand.

The market is divided into Three categories based on Application: Public health surveillance, Laboratory surveillance, Clinical diagnostics, and Others. Public Health Surveillance is the most significant segment of the Antimicrobial Resistance (AMR) Surveillance Market. This method involves collecting and analysing data on AMR to help health authorities monitor trends and outbreaks.

Public health surveillance is crucial for making informed policy decisions, guiding treatment plans, and effectively allocating resources. By identifying specific resistant strains in different populations, this approach enables targeted measures to mitigate the spread of resistance. Its role in improving patient outcomes and strengthening public health strategies makes it a key player in the AMR field, influencing future efforts in antimicrobial management and infection control.

Antimicrobial Resistance Surveillance Market- Geographical Insights

The Antimicrobial Resistance (AMR) Surveillance Market in North America is growing due to rising concerns about infections that do not respond to standard treatments. This region has well-established healthcare systems and regulatory bodies that support monitoring and research on AMR. Increased funding for healthcare initiatives and the development of advanced technologies are driving market growth.

Public awareness campaigns highlight the importance of tracking antibiotic resistance, further boosting the demand for surveillance Technology. Overall, North America is working to improve ways to fight antibiotic resistance and keep people healthy.

Antimicrobial Resistance Surveillance Market- Competitive Landscape:

The Antimicrobial Resistance (AMR) Surveillance market is growing rapidly because drug-resistant infections are becoming a bigger problem around the world. Companies like Thermo Fisher Scientific, bioMerieux, BD (Becton, Dickinson, and Company), and Cepheid are leading the way by creating advanced tools and systems to detect and track these resistant bacteria. They focus on testing methods, automated systems, and global networks to monitor resistance trends.

Collaborations between governments, healthcare organizations, and these companies are helping the market grow. Improvements in data analysis and machine learning are making it easier to predict AMR patterns, making this market very important for public health.

Recent Developments:

In February 2024, Visby Medical launched a rapid gonorrhea test that includes antimicrobial resistance profiling, addressing the growing challenge of resistant infections. This innovation aims to improve treatment effectiveness and public health management of gonorrhea

In November 2023, Ginkgo Bioworks and XWELL announced an expansion of their CDC traveler-based genomic surveillance program. This initiative aims to enhance public health efforts by testing for more than 30 known pathogens in travelers, thereby improving the ability to monitor and prevent potential outbreaks.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • bioMerieux
  • BD (Becton, Dickinson, and Company)
  • Cepheid
  • Roche Diagnostics
  • Abbott Laboratories
  • Meridian Bioscience
  • OpGen
  • T2 Biosystems
  • Luminex Corporation
  • Accelerate Diagnostics
  • Beckman Coulter
  • QIAGEN
  • Mast Group Ltd.
  • Antimicrobial Resistance Technology (AMRS) Global

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Microbiology Culture
  • Immunoassay
  • PCR
  • NGS
  • Mass Spectrometry
  • Rapid & Point of Care
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Public health surveillance
  • Laboratory surveillance
  • Clinical diagnostics
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antimicrobial Resistance Surveillance Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antimicrobial Resistance Surveillance Market Snippet by Technology
    • 2.1.2. Antimicrobial Resistance Surveillance Market Snippet by Application
    • 2.1.3. Antimicrobial Resistance Surveillance Market Snippet by End-User
    • 2.1.4. Antimicrobial Resistance Surveillance Market Snippet by Country
    • 2.1.5. Antimicrobial Resistance Surveillance Market Snippet by Region
  • 2.2. Competitive Insights

3. Antimicrobial Resistance Surveillance Key Market Trends

  • 3.1. Antimicrobial Resistance Surveillance Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antimicrobial Resistance Surveillance Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antimicrobial Resistance Surveillance Market Opportunities
  • 3.4. Antimicrobial Resistance Surveillance Market Future Trends

4. Antimicrobial Resistance Surveillance Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antimicrobial Resistance Surveillance Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antimicrobial Resistance Surveillance Market Landscape

  • 6.1. Antimicrobial Resistance Surveillance Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antimicrobial Resistance Surveillance Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2. Microbiology Culture
    • 7.1.3. Immunoassay
    • 7.1.4. PCR
    • 7.1.5. NGS
    • 7.1.6. Mass Spectrometry
    • 7.1.7. Rapid & Point of Care
    • 7.1.8. Others

8. Antimicrobial Resistance Surveillance Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Public health surveillance
    • 8.1.3. Laboratory surveillance
    • 8.1.4. Clinical diagnostics
    • 8.1.5. Other applications

9. Antimicrobial Resistance Surveillance Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Antimicrobial Resistance Surveillance Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Antimicrobial Resistance Surveillance Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Antimicrobial Resistance Surveillance Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Antimicrobial Resistance Surveillance Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Antimicrobial Resistance Surveillance Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Antimicrobial Resistance Surveillance Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Antimicrobial Resistance Surveillance Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. bioMerieux
    • 11.2.3. BD (Becton, Dickinson and Company)
    • 11.2.4. Cepheid
    • 11.2.5. Roche Diagnostics
    • 11.2.6. Abbott Laboratories
    • 11.2.7. Meridian Bioscience
    • 11.2.8. OpGen
    • 11.2.9. T2 Biosystems
    • 11.2.10. Luminex Corporation
    • 11.2.11. Accelerate Diagnostics
    • 11.2.12. Beckman Coulter
    • 11.2.13. QIAGEN
    • 11.2.14. Mast Group Ltd.
    • 11.2.15. Antimicrobial Resistance Technologys (AMRS) Global

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us